RE:RE:NEWS debt repayment 5 cent valuation.... Perfect, now we have 34.76 Million shares of overhang @ 5cts...
In addition, the Companyannounces that it was named in a statement of claim filed January 2019 by Cheryl Farmer, the former Chief Financial Officer of the Company, for wrongful dismissal in the amount of $2.5 million USD. The Company and the plaintiff have come to a satisfactory resolution and Lattice Biologics trusts that Ms. Farmer will have success in her future endeavors.
The Company reserved $600,000 Canadian in its most recent audited financial statements. The settlement includes a severance payment of $100,000 to be paid over 9 months, and 18 million shares at $.05 Canadian. The shares are subject to TSX approval, and all regulatory restrictions.
Lattice Biologics 16.76 million shares for debt 2020-05-28 17:25 ET - Shares for Debt The TSX Venture Exchange has accepted for filing the company's proposal to issue 16.76 million shares at a deemed price of five cents per share to settle outstanding debt for $838,000. Number of creditors: one creditor Insider: Guy Cook, $838,000, 16.76 million shares at five cents The company shall issue a news release when the shares are issued and the debt extinguished.